Clearly, increased FOXO3a expression plays a proapoptotic role, and once FOXO3a levels are reduced, the apoptosis rates in tumour cells decrease, which apparently represents a continuation of cancer cell progression. The gene discussed is FOXO3; the disease is neoplasm.